MichaelA.VogelbaumMDPh.D.

Brain & Spinal Tumor, Pituitary Surgery, Skull Base

Program Leader, NeuroOncology and Chief of Neurosurgery. Moffitt Cancer Center

Overview of Dr. Vogelbaum

Dr. Michael Vogelbaum is a neurosurgeon in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. He received his medical degree from University of Virginia School of Medicine and has been in practice 25 years. Dr. Vogelbaum accepts several types of health insurance, listed below. He is one of 19 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Neurosurgery. He has more than 100 publications and over 500 citings.

Office
12902 USF Magnolia Drive
Tampa, FL 33612
Book by Phone+1(813) 308-0848

Fax+1 813-745-3068
Is this information wrong?

Education & Training

Washington University/B-JH/SLCH ConsortiumResidency, Neurological Surgery, 1993 - 1999
Washington University/B-JH/SLCH ConsortiumInternship, Transitional Year, 1992 - 1993
University of Virginia School of MedicineClass of 1992

Certifications & Licensure

OH State Medical License 1999 - 2025
MO State Medical License 1998 - 2025
MI State Medical License 2002 - 2025
FL State Medical License 2018 - 2025
NY State Medical License 2003 - 2020
CT State Medical License 2003 - 2019
PA State Medical License 2003 - 2014
IL State Medical License 2002 - 2005
American Board of Neurological Surgery Neurological Surgery
Join now to see all

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Fellow (FACS) American College of Surgeons
Fellow (FAANS) American Association of Neurological Surgeons
Join now to see all

Clinical Trials

Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas Start of enrollment: 2002 Jul 01
Completed
Phase 2
Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme Start of enrollment: 2002 Aug 01
Unknown status
Phase 2
A Phase II Study Utilizing Focal Radiation in Patients With 1-3 Brain Metastases Start of enrollment: 2003 Dec 01
Cerebrospinal Fluid Levels of Erlotinib in Patients Receiving Erlotinib For Stage III Non-Small Cell Lung Cancer Start of enrollment: 2004 Jan 01
Completed
Not Applicable
Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH) Start of enrollment: 2007 Dec 01
Active, not recruiting
Phase 3
Radiosurgery Plus Bevacizumab in Glioblastoma Start of enrollment: 2010 Feb 01
Terminated
Early Phase 1
A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma Start of enrollment: 2010 Jul 01
Completed
Phase 1
Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor Start of enrollment: 2012 Feb 01
Completed
Phase 1
Topotecan in Glioma Undergoing A Clinically-Indicated Surgical Resection Start of enrollment: 2015 Jul 06
Terminated
Early Phase 1
Intratumorally-Administered Topotecan Using Convection-Enhanced Delivery in Patients With Grade III/ IV Glioma Start of enrollment: 2019 Jun 20
Terminated
Early Phase 1
Novel Exoscope System for 5-ALA Fluorescence-Guided Surgery for Gliomas Start of enrollment: 2019 Aug 15
Completed
A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511 Start of enrollment: 2011 Feb 01
Terminated
Phase 1
Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical Resection Start of enrollment: 2021 Mar 02
Terminated
Phase 1
Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases Start of enrollment: 2021 Nov 30
Recruiting
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

Challenges, Limitations and Pitfalls of PET and Advanced MRI in Patients with Brain Tumors - A Report of the PET/RANO Group.
Norbert Galldiks, Timothy J Kaufmann, Philipp Vollmuth, Philipp Lohmann, Marion Smits, Michael C Veronesi, Karl-Josef Langen, Roberta Rudá, Nathalie L Albert, Elke Hat...> ;Neuro-Oncology. 2024 Mar 11
ACTION: A randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma.
Lassman, A., Mueller, S., Nabors, B., van den Bent, M., Allen, J., Tarapore, R., Arrillaga-Romany, I., McGovern, S., Vogelbaum, M., Melemed, A., Wen, P., Cloughesy, T.> ;Neuro-Oncology. 2024 Mar 6
Clinical outcomes of melanoma brain metastases treated with nivolumab and ipilimumab alone versus nivolumab and ipilimumab with stereotactic radiosurgery.
Tang, J., Liu, J., Mills, M., Nakashima, J., Dohm, A., Khushalani, N., Forsyth, P., Vogelbaum, M., Wuthrick, E., Yu, H., Oliver, D., Ahmed, K.> ;Journal of Neuro-Oncology. 2024 Feb 1
2 citations
RANO 2.0: The revised Response Assessment in Neuro-Oncology (RANO) criteria for high- and low-grade glial tumors in adults designed for the future.
van den Bent, M., Wen, P., Vogelbaum, M., Chang, S.> ;Neuro-Oncology. 2024 Jan 5
Associations between recurrence patterns and outcome in glioblastoma patients undergoing re-resection: A complementary report of the RANO resect group.
Philipp Karschnia, Antonio Dono, Jacob S Young, Stephanie T Juenger, Nico Teske, Levin Häni, Tommaso Sciortino, Christine Y Mau, Francesco Bruno, Luis Nunez, Ramin A M...> ;Neuro-Oncology. 2024 Mar 4
Development of a "Geo-Tagged" tumor sample registry: intra-operative linkage of sample location to imaging.
John Lynes, Irfan Khan, Carlos Aguilera, Sebastian Rubino, Zachary Thompson, Arnold B Etame, James K C Liu, Andre Beer-Furlan, Nam D Tran, Robert J B Macaulay, Michael...> ;Journal of Neuro-Oncology. 2023 Dec 1
A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups.
Philipp Karschnia, Marion Smits, Guido Reifenberger, Emilie Le Rhun, Benjamin M Ellingson, Norbert Galldiks, Michelle M Kim, Jason T Huse, Oliver Schnell, Patrick N Ha...> ;The Lancet. Oncology. 2023 Nov 1
8 citations
RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults.
Patrick Y Wen, Martin van den Bent, Gilbert Youssef, Timothy F Cloughesy, Benjamin M Ellingson, Michael Weller, Evanthia Galanis, Daniel P Barboriak, John de Groot, Ma...> ;Journal of Clinical Oncology. 2023 Nov 20
The impact of opioid administration for post gamma knife radiosurgery frame removal: a prospective quality-improvement study.
Jason Hsieh, Wei Wei, Jeffrey Z Nie, Gene H Barnett, Alireza M Mohammadi, Glen Stevens, Michael Vogelbaum, Lilyana Angelov> ;Journal of Neuro-Oncology. 2023 Sep 1
Let the Guard Down: cAMP Activators Can Improve Immunotherapy in GBM.
Juyeun Lee, Kristen E Kay, Michael A Vogelbaum, Justin D Lathia> ;Cancer Immunology Research. 2023 Oct 4
12 citations
Prognostic evaluation of re-resection for recurrent glioblastoma using the novel RANO classification for extent of resection: A report of the RANO resect group.
Karschnia, P., Dono, A., Young, J., Juenger, S., Teske, N., Häni, L., Sciortino, T., Mau, C., Bruno, F., Nunez, L., Morshed, R., Haddad, A., Weller, M., van den Bent, ...> ;Neuro-Oncology. 2023 Sep 5
Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement (low-grade appearance): a report of the RANO resect group.
Philipp Karschnia, Jorg Dietrich, Francesco Bruno, Antonio Dono, Stephanie T Juenger, Nico Teske, Jacob S Young, Tommaso Sciortino, Levin Häni, Martin van den Bent, Mi...> ;Neuro-Oncology. 2024 Jan 5
CDK7 and CDK9 inhibition interferes with transcription, translation, and stemness, and induces cytotoxicity in GBM irrespective of temozolomide sensitivity.
Fatema Khambati, Shi-Yuan Cheng, Deanna M Tiek, Derek Duckett, Harshani Lawrence, Michael A Vogelbaum, Qianxing Mo, Srikumar P Chellappan, Jaya Padmanabhan, Isha Bhutada> ;Neuro-Oncology. 2024 Jan 5
2 citations
Stereotactic radiosurgery and anti-PD-1 + CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional chemotherapy fo...
Ammoren E Dohm, Justyn Y Nakashima, Hruday Kalagotla, Shirley X Jiang, Joseph D Tang, Menal Bhandari, Youngchul Kim, Jasmine A Graham, Nikhil I Khushalani, Peter A For...> ;European Journal of Cancer. 2023 Oct 1
1 citations
Tucatinib and stereotactic radiosurgery in the management of HER2 positive breast cancer brain metastases.
Vaseem M Khatri, Matthew N Mills, Daniel E Oliver, Hsiang-Hsuan Michael Yu, Michael A Vogelbaum, Peter A Forsyth, Hatem H Soliman, Hyo S Han, Kamran A Ahmed> ;Journal of Neuro-Oncology. 2023 Aug 1
7 citations
Correcting the drug development paradigm for glioblastoma requires serial tissue sampling.
Kirit Singh, Kelly M Hotchkiss, Ian F Parney, John De Groot, Solmaz Sahebjam, Nader Sanai, Michael Platten, Evanthia Galanis, Michael Lim, Patrick Y Wen, Giuseppe Minn...> ;Nature Medicine. 2023 Oct 1
The MIF promoter SNP rs755622 is associated with immune activation in glioblastoma.
Alban, T., Grabowski, M., Otvos, B., Bayik, D., Wang, W., Zalavadia, A., Makarov, V., Troike, K., McGraw, M., Rabljenovic, A., Lauko, A., Neumann, C., Roversi, G., Wai...> ;JCI Insight. 2023 Jul 10
42 citations
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.
Farshad Nassiri, Vikas Patil, Leeor S Yefet, Olivia Singh, Jeff Liu, Rachel M A Dang, Takafumi N Yamaguchi, Mariza Daras, Timothy F Cloughesy, Howard Colman, Priya U K...> ;Nature Medicine. 2023 Jun 1
1 citations
Author Correction: Federated learning enables big data for rare cancer boundary detection.
Sarthak Pati, Ujjwal Baid, Brandon Edwards, Micah Sheller, Shih-Han Wang, G Anthony Reina, Patrick Foley, Alexey Gruzdev, Deepthi Karkada, Christos Davatzikos, Chiharu...> ;Nature Communications. 2023 Jan 26
10 citations
Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trial.
John H Sampson, Achal Singh Achrol, Manish K Aghi, Krystof Bankiewicz, Martin Bexon, Steven Brem, Andrew Brenner, Chandtip Chandhasin, Sajeel Chowdhary, Melissa Coello...> ;Neuro-Oncology. 2023 Jun 2
10 citations
Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival.
Benjamin M Ellingson, Patrick Y Wen, Susan M Chang, Martin van den Bent, Michael A Vogelbaum, Gang Li, Shanpeng Li, Jiyoon Kim, Gilbert Youssef, Wolfgang Wick, Andrew ...> ;Neuro-Oncology. 2023 Jun 2
45 citations
Federated learning enables big data for rare cancer boundary detection.
Sarthak Pati, Ujjwal Baid, Brandon Edwards, Micah Sheller, Shih-Han Wang, G Anthony Reina, Patrick Foley, Alexey Gruzdev, Deepthi Karkada, Christos Davatzikos, Chiharu...> ;Nature Communications. 2022 Dec 5
3 citations
Trotabresib, an oral potent bromodomain and extraterminal inhibitor, in patients with high-grade gliomas: A phase I, "window-of-opportunity" study.
Victor Moreno, Juan Manuel Sepúlveda, David A Reardon, Ángel Pérez-Núñez, Pedro González León, Bishoy Hanna, Ellen Filvaroff, Ida Aronchik, Henry Chang, Barbara Amoros...> ;Neuro-Oncology. 2023 Jun 2
9 citations
Distinct Cell Adhesion Signature Defines Glioblastoma Myeloid-Derived Suppressor Cell Subsets.
Defne Bayik, Cynthia F Bartels, Katreya Lovrenert, Dionysios C Watson, Duo Zhang, Kristen Kay, Juyeun Lee, Adam Lauko, Sadie Johnson, Alice Lo, Daniel J Silver, Mary M...> ;Cancer Research. 2022 Nov 15
4 citations
Clinical outcomes of non-small cell lung cancer brain metastases treated with stereotactic radiosurgery and immune checkpoint inhibitors, EGFR tyrosine kinase inhibito...
Ammoren E Dohm, Joseph D Tang, Matthew N Mills, Casey L Liveringhouse, Maria L Sandoval, Bradford A Perez, Timothy J Robinson, Benjamin C Creelan, Jhanelle E Gray, Arn...> ;Journal of Neurosurgery. 2022 Nov 11
Join now to see all

Journal Articles

PET Imaging in Patients with Meningioma—Report of the RANO/PET Group
Michael Vogelbaum, MD, Neuro-Oncology

Authored Content

First-in-Human Evaluation of the Cleveland Multiport Catheter for Convection-Enhanced Delivery of Topotecan in Recurrent High-Grade Glioma: Results of Pilot Trial 1 RelatedApril 2018
First-in-Human Evaluation of the Cleveland Multiport Catheter for Convection-Enhanced Delivery of Topotecan in Recurrent High-Grade Glioma: Results of Pilot Trial 1 RelatedApril 2018

Press Mentions

ORBEYE Exoscope Blue Light Imaging Mode Now Available for Use in NeurosurgeryAugust 26th, 2022
Glioblastoma: Are Phase 0 Trials a Window of Opportunity in Drug Development?July 21st, 2022
Phase 0 Clinical Trials: What You Need to KnowJuly 21st, 2022
Join now to see all

Professional Memberships

Congress of Neurological Surgeons - CNS
Member
American Association of Neurological Surgeons - AANS
Fellow
American College of Surgeons - ACS
Member

Hospital Affiliations

H. Lee Moffitt Cancer Center and Research InstituteTampa, Florida

Insurance Accepted

Aetna Choice POS II
Aetna HMO
Anthem Blue Preferred HMO
BCBS Blue Card PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Great West PPO
Humana ChoiceCare Network PPO
Medical Mutual of Ohio SuperMed Plus
Medical Mutual of Ohio SuperMed POS
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment